481 related articles for article (PubMed ID: 31542837)
1. Clinical and pathological features of immunoglobulin A nephropathy patients with nephrotic syndrome.
Han X; Xiao Y; Tang Y; Zheng X; Anwar M; Qin W
Clin Exp Med; 2019 Nov; 19(4):479-486. PubMed ID: 31542837
[TBL] [Abstract][Full Text] [Related]
2. The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.
Li H; Wang F; Jia J; Yan T; Liu Y; Lin S
BMC Nephrol; 2022 Apr; 23(1):163. PubMed ID: 35488221
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of massive proteinuria in primary IgA nephropathy with and without nephrotic syndrome: a single center cohort study.
Hu Y; Huang Z; Cao Q; Chen B; Xu S; Qiu W; You X; Zhang J; Chen C
Ren Fail; 2023; 45(2):2267138. PubMed ID: 37850851
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic significance of C1q deposition in IgAN patients-a retrospective study.
Tian S; Yang X; Luo J; Guo H
Int Immunopharmacol; 2020 Nov; 88():106896. PubMed ID: 33182045
[TBL] [Abstract][Full Text] [Related]
5. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
6. IgA nephropathy with presentation of nephrotic syndrome at onset in children.
Shima Y; Nakanishi K; Sato M; Hama T; Mukaiyama H; Togawa H; Tanaka R; Nozu K; Sako M; Iijima K; Suzuki H; Yoshikawa N
Pediatr Nephrol; 2017 Mar; 32(3):457-465. PubMed ID: 27714465
[TBL] [Abstract][Full Text] [Related]
7. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients.
Chai L; Cai K; Wang K; Luo Q
J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240
[TBL] [Abstract][Full Text] [Related]
8. Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?
Chen Y; Yang A; Hou Y; Liu L; Lin J; Huang X; Li J; Liu X; Lu F; Lin Q; Yang H; Yue S; Jiang S; Wang L; Zou C
Ren Fail; 2022 Dec; 44(1):1443-1453. PubMed ID: 36017686
[TBL] [Abstract][Full Text] [Related]
9. Comparison between patients with IgA nephropathy with minimal change disease and patients with minimal change disease.
Li XW; Cheng SQ; Liang SS; Le WB; Zeng CH; Wang JQ; Liu ZH
Clin Nephrol; 2016 May; 85(5):273-81. PubMed ID: 26951969
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.
Kim JK; Kim JH; Lee SC; Kang EW; Chang TI; Moon SJ; Yoon SY; Yoo TH; Kang SW; Choi KH; Han DS; Kie JH; Lim BJ; Jeong HJ; Han SH
Clin J Am Soc Nephrol; 2012 Mar; 7(3):427-36. PubMed ID: 22223610
[TBL] [Abstract][Full Text] [Related]
11. Severity of nephrotic IgA nephropathy according to the Oxford classification.
Moriyama T; Nakayama K; Iwasaki C; Ochi A; Tsuruta Y; Itabashi M; Tsukada M; Takei T; Uchida K; Nitta K
Int Urol Nephrol; 2012 Aug; 44(4):1177-84. PubMed ID: 22231129
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological Characteristics and Outcomes of Immunoglobulin A Nephropathy with Different Types of Dyslipidemia: A Retrospective Single-Center Study.
Liu S; Lu Z; Fu Z; Li H; Gui C; Deng Y
Kidney Blood Press Res; 2023; 48(1):186-193. PubMed ID: 37062274
[TBL] [Abstract][Full Text] [Related]
13. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy.
Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518
[TBL] [Abstract][Full Text] [Related]
14. Mild mesangial proliferative IgA nephropathy with and without minimal change disease.
Wang S; Huang B; Wang P; Liu Y; Liu Y; Chen H; Zhang J
Clin Exp Med; 2023 Dec; 23(8):5367-5376. PubMed ID: 37796359
[TBL] [Abstract][Full Text] [Related]
15. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of IgA nephropathy with minimal change disease: a comparison between patients with and without minimal change disease.
Li XW; Liang SS; Le WB; Cheng SQ; Zeng CH; Wang JQ; Liu ZH
J Nephrol; 2016 Aug; 29(4):567-73. PubMed ID: 26537358
[TBL] [Abstract][Full Text] [Related]
17. Long-term renal survival and undetected risk factors of IgA nephropathy in Chinese children-a retrospective 1243 cases analysis from single centre experience.
Wu H; Fang X; Xia Z; Gao C; Peng Y; Li X; Zhang P; Kuang Q; Wang R; Wang M
J Nephrol; 2020 Dec; 33(6):1263-1273. PubMed ID: 32507961
[TBL] [Abstract][Full Text] [Related]
18. Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy.
Yang Y; Tang X; Yang Y; Li X; Li L; Huang K; Li Y; Li J; Fu P
Ren Fail; 2020 Nov; 42(1):629-637. PubMed ID: 32660366
[TBL] [Abstract][Full Text] [Related]
19. [Retrospective Analysis of the Effect of Uric Acid on the Prognosis of Immunoglobulin A Nephropathy With Stage 3-4 Chronic Kidney Disease].
Yu Z; Qin Y; Yuan J; Zhao J; Sun S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1121-1127. PubMed ID: 38162075
[TBL] [Abstract][Full Text] [Related]
20. Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience.
Mohd R; Mohammad Kazmin NE; Abdul Cader R; Abd Shukor N; Wong YP; Shah SA; Alfian N
PLoS One; 2021; 16(4):e0249592. PubMed ID: 33831052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]